by Raynovich Rod | Jan 27, 2015 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
3:55 p FEDspeak confuses markets with S&P down 1.25% Too much money around too little yield=deflation concerns. Energy takes a big hit again down 4%. Biotechs off 2% and more. ——— Update 1/28 Technology outperforming biotech in mid-day trading...
by Raynovich Rod | Jan 21, 2015 | Biopharmaceuticals
NASDAQ at 4667 up 0.27% XBI at $194.4 down 2.88% Clinical Stage Immuno-oncology Stocks Hit Hard Again Momentum traders took money off the table for the second time in three days. Most large cap biopharmaceutical stocks were in the red but down less than 1 %...
by Raynovich Rod | Jan 15, 2015 | Biopharmaceuticals, Macro
Update Next Day…Green Screen in Biotech…1/16…Complete reversal all up XBI at $197.95 UP 3% AGIO up 3.6%, BLUE up 4.78%, JUNO up 12.4%, KITE up 10.2%, NLNK up 2.4%, PBYI up 9.4%, ZIOP up 1.76% Red Screen Day in Biotech NASDAQ 4584 down 1.18% Euro...
by Raynovich Rod | Dec 19, 2014 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals, Macro
Biotech Stocks Rally to New Highs After 4% Correction Buyers Are Bottom Feeding Energy Stocks NASDAQ at 4765 Just as the market appeared to be headed to another test of October lows, challenged by news on slowing global growth and a collapsing energy sector, FED Chair...
by Raynovich Rod | Dec 11, 2014 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Part 1 Biopharmaceutical Stocks-New Highs Were Hit on December 10 Five Straight Years of Gains in Biotech-the IBB is up 292% since Dec 18, 2009 Biotech stocks are following the long term seasonal bullish trend surging in Q4 and up about 49 % YTD. The easiest way to...
by Raynovich Rod | Dec 1, 2014 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Bounce Back Day 12/2/14 FBT up 1.5% to $102.33 Biotech players realized that news about China, energy and holiday shopping data do not affect their stocks. Our large cap biopharma portfolio went green helped by Biogen Idec (BIIB) up 6.43% on Phase 1a data for an...
by Raynovich Rod | Oct 13, 2014 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals, Macro
10/14 …Update 3:10p Here come the sellers late in the day on schedule. Investors are trying to hold the fort. Oil down, treasuries up, JPMorgan misses off 0.43%. XLE off 0.57%, Gold steady at 1233, biotechs mixed but GILD down 5%, industrials and technology in...
by Raynovich Rod | Oct 9, 2014 | Biopharmaceuticals, Macro
Five Year Bull Market in Biotech We attended the Bio Investor Forum in San Francisco this week and it was well attended with over 600 participants and over 120 companies presenting. Attendees included VCs , investors, industry executives, bankers, and media. The Bio...
by Raynovich Rod | Oct 6, 2014 | 2025 Rayno Biopharmaceuticals Portfolio
NASDAQ Slides After Good Opening -Down 0.47% The enthusiasm generated by Friday’s jobs report waned after the opening. The shocking 92% decline in shares of GT Advanced Technologies , Inc.(GTAT) due to a bankruptcy filing rattled traders and drove small cap...
by Raynovich Rod | Oct 1, 2014 | 2024 Rayno Tools and Diagnostics Portfolio, 2025 Rayno Biopharmaceuticals Portfolio
10/3 Jobs Report Clears Path for Q4 Rally 3:30P EDT A more optimistic view of the economy was triggered by a steady gain in jobs with 248k added in August and unemployment dropping below 6% to 5.9%. But average hourly wages fell in September keeping wage growth...
